StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO)

Equities researchers at StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research report issued on Wednesday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Trading Down 4.4 %

Shares of NASDAQ TTOO opened at $0.12 on Wednesday. T2 Biosystems has a one year low of $0.06 and a one year high of $6.80. The firm’s 50 day simple moving average is $0.16 and its two-hundred day simple moving average is $0.71.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.